Yuval Cohen, Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), sold 14,268 shares at $8.76 ($125K) on 2025-02-14, disclosed to the SEC on 2025-02-18.
Scheduled sale ($125k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.76 | 7,134 | $62K | 50.0% |
| 2 | $8.76 | 7,134 | $62K | 50.0% |
| Total | $8.76 avg | 14,268 | $125K | 100% |
| Filing → |
| CRBP | SELL | 2025-10-27 | $942K | — | Filing → |
| CRBP | SELL | 2024-06-18 | $5.9M | — | Filing → |
| CRBP | BUY | 2022-08-11 | $988 | — | Filing → |